Validation of prostate‐specific antigen laboratory values recorded in Surveillance, Epidemiology, and End Results registries

BACKGROUND Researchers have used prostate‐specific antigen (PSA) values collected by central cancer registries to evaluate tumors for potential aggressive clinical disease. An independent study collecting PSA values suggested a high error rate (18%) related to implied decimal points. To evaluate the...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cancer 2017-02, Vol.123 (4), p.697-703
Hauptverfasser:	Adamo, Margaret (Peggy), Boten, Jessica A., Coyle, Linda M., Cronin, Kathleen A., Lam, Clara J. K., Negoita, Serban, Penberthy, Lynne, Stevens, Jennifer L., Ward, Kevin C.
Format:	Artikel
Sprache:	eng
Schlagworte:	and End Results (SEER) program Antigens Cancer Categories Classification Coding Communication Consolidation data quality Documentation Epidemiology Error analysis Error correction Humans implied decimal Laboratories laboratory value Male Neoplasm Staging Oncology Predictive Value of Tests Prostate cancer Prostate-specific antigen Prostate-Specific Antigen - blood prostate‐specific antigen (PSA) Prostatic Neoplasms - blood Prostatic Neoplasms - epidemiology Prostatic Neoplasms - pathology Quality control Researchers Reviewing SEER Program staging Studies Surveillance Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!